Compare LGVN & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LGVN | JRSH |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 38.5M |
| IPO Year | 2021 | 2017 |
| Metric | LGVN | JRSH |
|---|---|---|
| Price | $1.04 | $3.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $3.00 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 889.7K | 52.2K |
| Earning Date | 05-07-2026 | 02-09-2026 |
| Dividend Yield | N/A | ★ 6.21% |
| EPS Growth | 50.76 | ★ 56.25 |
| EPS | N/A | ★ 0.15 |
| Revenue | $709,000.00 | ★ $145,812,006.00 |
| Revenue This Year | N/A | $11.64 |
| Revenue Next Year | $10.81 | $10.06 |
| P/E Ratio | ★ N/A | $21.47 |
| Revenue Growth | N/A | ★ 24.43 |
| 52 Week Low | $0.48 | $2.82 |
| 52 Week High | $1.83 | $3.60 |
| Indicator | LGVN | JRSH |
|---|---|---|
| Relative Strength Index (RSI) | 52.01 | 73.94 |
| Support Level | $0.69 | $3.20 |
| Resistance Level | $1.23 | $3.52 |
| Average True Range (ATR) | 0.10 | 0.10 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 33.87 | 94.39 |
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.